MEDCAW INVESTMENTS LS-01 (F:U09) — Market Cap & Net Worth

$711.56K USD  · €608.63K EUR  · Rank #30400

Market Cap & Net Worth: MEDCAW INVESTMENTS LS-01 (U09)

MEDCAW INVESTMENTS LS-01 (F:U09) has a market capitalization of $711.56K (€608.63K) as of May 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #30400 globally and #2692 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDCAW INVESTMENTS LS-01's stock price €0.03 by its total outstanding shares 22132095 (22.13 Million).

MEDCAW INVESTMENTS LS-01 Market Cap History: 2023 to 2026

MEDCAW INVESTMENTS LS-01's market capitalization history from 2023 to 2026. Data shows change from $1.05 Million to $711.56K (-34.78% CAGR).

MEDCAW INVESTMENTS LS-01 Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how MEDCAW INVESTMENTS LS-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of U09 by Market Capitalization

Companies near MEDCAW INVESTMENTS LS-01 in the global market cap rankings as of May 4, 2026.

Key companies related to MEDCAW INVESTMENTS LS-01 by market ranking:

  • BlackRock Inc (NYSE:BLK): Ranked #140 globally with a market cap of $155.79 Billion USD.
  • Brookfield Corporation (TO:BN): Ranked #245 globally with a market cap of $99.82 Billion USD ( CA$137.99 Billion CAD).
  • Blackstone Group Inc (NYSE:BX): Ranked #267 globally with a market cap of $94.60 Billion USD.
  • KKR & Co LP (NYSE:KKR): Ranked #280 globally with a market cap of $92.43 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#140 BlackRock Inc NYSE:BLK $155.79 Billion $1061.68
#245 Brookfield Corporation TO:BN $99.82 Billion CA$61.48
#267 Blackstone Group Inc NYSE:BX $94.60 Billion $126.35
#280 KKR & Co LP NYSE:KKR $92.43 Billion $103.68

MEDCAW INVESTMENTS LS-01 Historical Marketcap From 2023 to 2026

Between 2023 and today, MEDCAW INVESTMENTS LS-01's market cap moved from $1.05 Million to $ 711.56K, with a yearly change of -34.78%.

Year Market Cap Change (%)
2026 €711.56K 0.00%
2025 €711.56K -32.10%
2024 €1.05 Million 0.00%
2023 €1.05 Million --

End of Day Market Cap According to Different Sources

On May 3rd, 2026 the market cap of MEDCAW INVESTMENTS LS-01 was reported to be:

Source Market Cap
Yahoo Finance $711.56K USD
MoneyControl $711.56K USD
MarketWatch $711.56K USD
marketcap.company $711.56K USD
Reuters $711.56K USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About MEDCAW INVESTMENTS LS-01

F:U09 Germany Asset Management
Market Cap
$711.56K
€608.63K EUR
Market Cap Rank
#30400 Global
#2692 in Germany
Share Price
€0.03
Change (1 day)
+0.00%
52-Week Range
€0.03 - €0.04
All Time High
€0.11
About

Medcaw Investments Plc does not have significant operations. It focuses on identifying acquisition opportunities. The company was incorporated in 2020 and is based in London, the United Kingdom.